Tremfya Leads TV Pharma Ads in September and Q3
Johnson & Johnson's Tremfya retained its top spot for TV pharma brand ad impressions in September, with a 5.02% share of voice and 3.1 billion impressions, following an ad spend of $32.8 million.
- Tremfya's impressions were largely driven by Univision's ¡Despierta América!
- Vicks took the runner-up title, with a 4.71% share of voice and 2.9 billion impressions, primarily through CBS and GMA 3: What You Need to Know.
- Skyrizi, from AbbVie, was knocked to third place, with 2 billion impressions.
The fall sports season, including college football, and Spanish language TV delivered the majority of TV pharma ad impressions in September.
The Proctor and Gamble brand Vicks invested $10.3 million into its TV ad spend for September, while Tremfya spent approximately $10 million more than in August.
Author's summary: Tremfya leads TV pharma ads.